Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes - Radioactive & Nonradioactive

Synthesis and initial biological evaluation of GRP78 targeted peptides for molecular imaging of metastatic melanoma

Somya Kapoor, Molly Martin and Michael Schultz
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 443;
Somya Kapoor
1Free Radical and Radiation Biology Program, Department of Radiation Oncology, University of Iowa, Iowa City, IA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Molly Martin
3Department of Pediatrics, University of Iowa, Iowa City, IA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Schultz
2Radiology and Radiation Oncology, Free Radical and Radiation Biology Program, University of Iowa, Iowa City, IA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

443

Objectives GRP78 is a 78 kDa protein that plays major roles as a molecular chaperone and in the unfolded protein response in the endoplasmic reticulum. Emerging evidence suggests that cellular stress in the tumor microenvironment (e.g., oxidative stress) leads to a remarkable increase in the expression of GRP78 within cells and at the cell surface (1-4). This study aims to establish a backbone to develop cell-surface GRP78 targeted peptides for PET imaging of melanoma.

Methods Variation in GRP78 expression was studied in B16 melanoma tumors, HepG2 and melanocytes by immunochemistry (IHC). Seven GRP78 targeted peptide derivatives with micromolar affinity (8 to 13-mer in length) were synthesized based on previous studies in which peptides with were selected by bacteriophage techniques for other applications (2-4). Three linear and four cyclized derivatives were modified with a DOTA chelator and a fluorescent (fluorescein) moiety. DOTA conjugates were labeled with Ga-68 in acetate buffer at 99 °C.

Results IHC staining of melanoma tumor cross sections shows a remarkable difference in the expression of GRP78 in tumors vs adjacent tissue. Immunofluorescence studies show expression of GRP78 on the surface of HepG2 cells increases upon incubation with 50 µM hydrogen peroxide - evidence that enhanced expression can be induced by oxidative stress. Fluorescein-labeled-cyclized derivatives were internalized and binding affinity did not depend on the position of DOTA/fluorescein. DOTA derivatives were efficiently labeled with Ga-68.

Conclusions GRP78 is emerging as a target for PET imaging. Cell surface expression appears to be mediated by stress mechanisms. DOTA conjugated GRP78 targeted peptides can be labeled with Ga-68 for PET. Further studies are needed to improve the affinity of GRP78 targeted peptides for PET imaging of melanoma.

Research Support NRC-HQ-12-G-38-0041; NIH 1R01CA167632-01, K25CA172218-01A1; UI HCC.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 55, Issue supplement 1
May 2014
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Synthesis and initial biological evaluation of GRP78 targeted peptides for molecular imaging of metastatic melanoma
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Synthesis and initial biological evaluation of GRP78 targeted peptides for molecular imaging of metastatic melanoma
Somya Kapoor, Molly Martin, Michael Schultz
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 443;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Synthesis and initial biological evaluation of GRP78 targeted peptides for molecular imaging of metastatic melanoma
Somya Kapoor, Molly Martin, Michael Schultz
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 443;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Probes - Radioactive & Nonradioactive

  • Assessment of α4β2 nicotinic acetylcholine receptor (nAChR) availability and neuronal response to rewarding food-cues in human obesity using simultaneous PET-MRI
  • Bridging brain structural/functional connectivity and tau load in PSP: A [18F]PI-2620 PET/MRI study
  • MACROPA highly stable chelator of Radium-223 and functionalization attempts for targeted treatment of cancer
Show more Molecular Targeting Probes - Radioactive & Nonradioactive

Peptide-Based Oncology Imaging Probes

  • Synthesis and evaluation of monomeric, dimeric and trimeric benzenesulfonamide derivatives for imaging carbonic anhydrase IX with PET
  • 68Ga labeled integrin a2b1 tracer for potential phenotyping imaging of metastatic prostate cancer
Show more Peptide-Based Oncology Imaging Probes

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire